Source link : https://www.newshealth.biz/health-news/fda-oks-first-in-class-nonopioid-pain-med-suzetrigine/
The US Food and Drug Administration (FDA) has approved suzetrigine 50 mg tablets (Journavx, Vertex Pharmaceuticals), a first-in-class nonopioid analgesic for treatment of adults with moderate-to-severe acute pain. Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system, a validated target for peripheral pain management. Because suzetrigine blocks pain signals found only in […]
Author : News Health
Publish date : 2025-01-31 15:29:46
Copyright for syndicated content belongs to the linked Source.